MCID: MYF002
MIFTS: 41

Myofascial Pain Syndrome

Categories: Muscle diseases

Aliases & Classifications for Myofascial Pain Syndrome

MalaCards integrated aliases for Myofascial Pain Syndrome:

Name: Myofascial Pain Syndrome 12 15
Myofascial Pain Syndromes 44 73
Myofascial Pain Dysfunction Syndrome 55
Fibromyalgia 73

Classifications:



External Ids:

Disease Ontology 12 DOID:431
MeSH 44 D009209

Summaries for Myofascial Pain Syndrome

MalaCards based summary : Myofascial Pain Syndrome, also known as myofascial pain syndromes, is related to fibromyalgia and chronic fatigue syndrome, and has symptoms including muscle weakness, fatigue and myoclonus. An important gene associated with Myofascial Pain Syndrome is POMC (Proopiomelanocortin). The drugs Etoricoxib and Naltrexone have been mentioned in the context of this disorder. Affiliated tissues include testes, spinal cord and skeletal muscle, and related phenotypes are hematopoietic system and immune system

Wikipedia : 76 Myofascial pain syndrome (MPS), also known as chronic myofascial pain (CMP), is a syndrome characterized... more...

Related Diseases for Myofascial Pain Syndrome

Diseases related to Myofascial Pain Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 33)
# Related Disease Score Top Affiliating Genes
1 fibromyalgia 11.9
2 chronic fatigue syndrome 10.3
3 bruxism 10.1
4 reflex sympathetic dystrophy 10.0
5 anxiety 10.0
6 algoneurodystrophy 10.0
7 pain - chronic 10.0
8 premenstrual tension 10.0 CAMP POMC
9 mucolipidosis iii alpha/beta 10.0
10 joint disorders 10.0
11 pulpitis 10.0
12 glossopharyngeal neuralgia 10.0
13 epicondylitis 9.9 NDUFB8 TAC1
14 neurodermatitis 9.9 POMC TAC1
15 breast cancer 9.9
16 temporal arteritis 9.9
17 trigeminal neuralgia 9.9
18 fibrosclerosis, multifocal 9.9
19 angioma, tufted 9.9
20 hemangioma 9.9
21 osteoarthritis 9.9
22 bursitis 9.9
23 adenocarcinoma 9.9
24 intramuscular hemangioma 9.9
25 neuropathy 9.9
26 retroperitoneal fibrosis 9.9
27 depression 9.9
28 headache 9.9
29 anismus 9.9 CAMP TAC1
30 pain agnosia 9.8 POMC TAC1
31 brachial plexus lesion 9.8 CAMP TAC1
32 agnosia 9.8 POMC TAC1
33 specific developmental disorder 9.7 POMC TAC1

Graphical network of the top 20 diseases related to Myofascial Pain Syndrome:



Diseases related to Myofascial Pain Syndrome

Symptoms & Phenotypes for Myofascial Pain Syndrome

UMLS symptoms related to Myofascial Pain Syndrome:


muscle weakness, fatigue, myoclonus, back pain, myalgia, pain, torticollis, chronic pain, sciatica, muscle rigidity, muscle cramp, muscle spasticity, myofascial trigger point pain

MGI Mouse Phenotypes related to Myofascial Pain Syndrome:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.35 CAMP NDUFB8 PDGFRB POMC PSTPIP1
2 immune system MP:0005387 9.02 CAMP NDUFB8 PDGFRB POMC PSTPIP1

Drugs & Therapeutics for Myofascial Pain Syndrome

Drugs for Myofascial Pain Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 356)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
2
Naltrexone Approved, Investigational, Vet_approved Phase 4,Phase 2,Not Applicable 16590-41-3 5360515
3 tannic acid Approved Phase 4,Phase 1,Phase 2,Not Applicable
4
Benzocaine Approved, Investigational Phase 4,Phase 1,Phase 2,Not Applicable 94-09-7, 1994-09-7 2337
5
Milnacipran Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 92623-85-3 65833
6
Amitriptyline Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 50-48-6 2160
7
Cyclobenzaprine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 303-53-7 2895
8
Dinoprostone Approved Phase 4 363-24-6 5280360
9
Norepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-41-2 439260
10
Gabapentin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 60142-96-3 3446
11
gamma-Aminobutyric acid Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 56-12-2 119
12
Perphenazine Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 58-39-9 4748
13
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 148553-50-8 5486971
14
Acetylcholine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-84-3 187
15
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 137-58-6 3676
16
Dopamine Approved Phase 4,Phase 3,Phase 2,Not Applicable 51-61-6, 62-31-7 681
17
Tramadol Approved, Investigational Phase 4,Phase 3,Phase 2 27203-92-5 33741
18
Acetaminophen Approved Phase 4,Phase 3,Phase 2,Not Applicable 103-90-2 1983
19
Naloxone Approved, Vet_approved Phase 4,Phase 2,Phase 1,Not Applicable 465-65-6 5284596
20
Paroxetine Approved, Investigational Phase 4,Phase 1,Phase 2 61869-08-7 43815
21
Trazodone Approved, Investigational Phase 4 19794-93-5 5533
22
Fluoxetine Approved, Vet_approved Phase 4,Phase 3,Phase 2 54910-89-3 3386
23
Eszopiclone Approved, Investigational Phase 4 138729-47-2 969472
24
Colchicine Approved Phase 4 64-86-8 6167 2833
25
Armodafinil Approved, Investigational Phase 4,Phase 3 112111-43-0
26
Modafinil Approved, Investigational Phase 4,Phase 3 68693-11-8 4236
27
Hydrocortisone Approved, Vet_approved Phase 4,Early Phase 1,Not Applicable 50-23-7 5754
28
Hydrocortisone acetate Approved, Vet_approved Phase 4,Early Phase 1,Not Applicable 50-03-3
29
Granisetron Approved, Investigational Phase 4 109889-09-0 3510
30
Iron Approved Phase 4,Phase 3,Phase 2 7439-89-6 23925
31
Deferasirox Approved, Investigational Phase 4 201530-41-8 5493381
32
Betamethasone Approved, Vet_approved Phase 4 378-44-9 9782
33
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 1 9004-61-9 53477741
34
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2 51-45-6, 75614-87-8 774
35
Sodium oxybate Approved Phase 4,Phase 3,Phase 2 502-85-2 5360545
36
Flunarizine Approved Phase 4 52468-60-7 941361
37
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
38
Suvorexant Approved, Investigational Phase 4 1030377-33-3
39
Buprenorphine Approved, Illicit, Investigational, Vet_approved Phase 4 52485-79-7 40400 644073
40
Ergocalciferol Approved, Nutraceutical Phase 4 50-14-6 5280793
41
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4 1406-16-2
42
Glutamic Acid Approved, Nutraceutical Phase 4,Not Applicable 56-86-0 33032
43
Vitamin D3 Approved, Nutraceutical Phase 4 67-97-0 5280795 6221
44 Cyclooxygenase 2 Inhibitors Phase 4,Phase 2
45 Analgesics Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
46 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
47 Anti-Inflammatory Agents Phase 4,Phase 2,Phase 1,Not Applicable,Early Phase 1
48 Cyclooxygenase Inhibitors Phase 4,Phase 2,Phase 1,Not Applicable
49 Analgesics, Non-Narcotic Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
50 Antirheumatic Agents Phase 4,Phase 2,Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 888)
# Name Status NCT ID Phase Drugs
1 Study Assessing the Efficacy of Etoricoxib in Female Patients With Fibromyalgia Unknown status NCT00755521 Phase 4 etoricoxib
2 Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism? Unknown status NCT02806440 Phase 4 Low dose naltrexone;Placebo
3 Study of Fibromyalgia Treated With Milnacipran Unknown status NCT01125423 Phase 4 Milnacipran
4 Cyclobenzaprine Extended Release (ER) for Fibromyalgia Unknown status NCT01041495 Phase 4 cyclobenzaprine ER (AMRIX);placebo
5 The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain Unknown status NCT01417923 Phase 4 vitamin D
6 Study to Evaluate the Efficacy of Milnacipran in the Treatment of Pain Due to Osteoarthritis Unknown status NCT01329406 Phase 4 Milnacipran;Placebo
7 The Impact of Perioperative Gabapentin on Chronic Groin Pain After Inguinal Hernia Repair Unknown status NCT02419443 Phase 4 Gabapentin;Placebo
8 Quetiapine Compared With Placebo in the Management of Fibromyalgia Completed NCT01458964 Phase 4 Quetiapine
9 Effect of Milnacipran on Pain in Fibromyalgia Completed NCT01288807 Phase 4 Milnacipram
10 Valuation of Efficacy and Safety of Vitamin D3 Use in 80 Women Diagnosed With Fibromyalgia. Using FIQ Score and VAS. Completed NCT03369379 Phase 4 D3 Vitamin
11 Pool-based Exercise in Fibromyalgia Management Completed NCT00550641 Phase 4
12 Comparative Efficacy and Tolerability of Quetiapine XR and Amitriptyline in the Treatment of Fibromyalgia Completed NCT00766350 Phase 4 amitriptyline;quetiapine
13 Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome Completed NCT00610610 Phase 4 Paroxetine CR;Placebo
14 Quetiapine (Seroquel XR) for the Treatment of Fibromyalgia: a Clinical and Mechanistic Pilot Study Completed NCT00983320 Phase 4 quetiapine;placebo
15 Strengthening Exercises for Fibromyalgia Completed NCT02063750 Phase 4
16 A Pilot Study on the Use of Nociceptive Flexion Reflex for Fibromyalgia Completed NCT00965601 Phase 4
17 Trazodone and Its Augmentation With Pregabalin in the Treatment of Fibromyalgia Completed NCT00791739 Phase 4 trazodone, pregabalin
18 Combining N-of-1 Trials to Assess Fibromyalgia Treatments Completed NCT00000428 Phase 4 Amitriptyline;Amitriptyline plus Fluoxitine
19 Discomfort and Psychosocial Difficulties in Fibromyalgia Completed NCT02078791 Phase 4 Botox infiltration
20 Discontinuation Study of the Durability of Effect of Milnacipran for the Treatment of Fibromyalgia Completed NCT01014585 Phase 4 Placebo;Milnacipran
21 Drug and Talk Therapy for Fibromyalgia Completed NCT01038323 Phase 4 Educational with milnacipran
22 Adolescent Fibromyalgia Study Completed NCT01020474 Phase 4 placebo;pregabalin (Lyrica)
23 Heart Rate Variability in Fibromyalgia - Effects of Strengthening Exercises Completed NCT02004405 Phase 4
24 Treatment of Myofascial Pain Syndrome With Lidocaine Injection and Physical Therapy. Completed NCT01250184 Phase 4 Lidocaine injection
25 Fixed Versus Flexible Dosing of Pregabalin in Patients With Fibromyalgia Completed NCT01226667 Phase 4 Pregabalin
26 Ai Chi Versus Stretching in Fibromyalgia Management Completed NCT00600574 Phase 4
27 A Study for Adult Patients With Fibromyalgia Completed NCT00965081 Phase 4 Duloxetine;Placebo
28 A Study to Evaluate the Effects of Milnacipran on Pain Processing and Functional MRI in Patients With Fibromyalgia Completed NCT01173055 Phase 4 milnacipran;Placebo
29 The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia Completed NCT01234675 Phase 4 Milnacipran;Milnacipran
30 Eszopiclone in the Treatment of Insomnia and Fibromyalgia Completed NCT00392041 Phase 4 Eszopiclone;placebo
31 Pregabalin In Adolescent Patients With Fibromyalgia Completed NCT01020526 Phase 4 pregabalin
32 An Efficacy Study of Combination of Tramadol and Acetaminophen Tablets in the Treatment of Participants With Fibromyalgia Pain Completed NCT00766675 Phase 4 Tramadol hydrochloride;Acetaminophen
33 Study of Milnacipran in Patients With Inadequate Response to Duloxetine for the Treatment of Fibromyalgia Completed NCT01077375 Phase 4 Placebo;Milnacipran
34 A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia Completed NCT00673452 Phase 4 duloxetine hydrochloride;placebo
35 EMINEM: Efficacy of Muscoril In NEck Myofascial Syndromes Completed NCT00272532 Phase 4 Thiocolchicoside
36 An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia Fatigue Completed NCT00678691 Phase 4 armodafinil;placebo
37 A Study of Quetiapine Fumarate Sustained Release in Major Depression With Comorbid Fibromyalgia Syndrome Completed NCT00675896 Phase 4 Quetiapine Fumarate Sustained Release;Placebo
38 Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome Completed NCT00241215 Phase 4 Botulinum toxin serotype A
39 Patient Self-administration of Cortisol for Cortisol-responding Disorders in Men and Women Over the Age of 17 Completed NCT03558971 Phase 4 Cortisol
40 Milnacipran for Chronic Pain in Knee Osteoarthritis Completed NCT01510457 Phase 4 Milnacipran;Placebo
41 Comparison of the Efficacy of Duloxetine With Placebo in Patients With Chronic Low Back Pain With a Radicular Component Completed NCT01166048 Phase 4 Duloxetine;Duloxetine
42 Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome Completed NCT01071044 Phase 4 Lisdexamfetamine Dimesylate;Placebo "30, 50 or 70 mg"
43 Study on the Effect of Granisetron on Myofascial Pain in the Orofacial Muscles Completed NCT02230371 Phase 4 Granisetron;Control (placebo)
44 Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload Completed NCT00673608 Phase 4 deferasirox
45 A Double Blind Study Comparing Hyaluronic Acid, Corticosteroid and Placebo During Arthrocentesis for Temporomandibular Joint (TMJ) Dysfunction Completed NCT01524913 Phase 4 Hyaluronic acid;Corticosteroid;Lactated Ringers
46 Neurologic Signatures of Chronic Pain Disorders Recruiting NCT02747940 Phase 4 flunarizine and/or pregabalin
47 Pharmacokinetics of Two Formulation of Pregabalin Active, not recruiting NCT03712475 Phase 4 Pregabalin
48 Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty Enrolling by invitation NCT03271151 Phase 4 Cymbalta
49 Using Saline for Myofascial Pain Syndromes (USAMPS) Terminated NCT02120261 Phase 4
50 Influence of Transcranial Direct Current Stimulation of the Primary Motor Cortex on Pain Sensation in Patients Suffering From Fibromyalgia Syndrome Terminated NCT01261650 Phase 4

Search NIH Clinical Center for Myofascial Pain Syndrome

Cochrane evidence based reviews: myofascial pain syndromes

Genetic Tests for Myofascial Pain Syndrome

Anatomical Context for Myofascial Pain Syndrome

MalaCards organs/tissues related to Myofascial Pain Syndrome:

41
Testes, Spinal Cord, Skeletal Muscle, Skin, Breast, Bone

Publications for Myofascial Pain Syndrome

Articles related to Myofascial Pain Syndrome:

(show top 50) (show all 302)
# Title Authors Year
1
Pathophysiology and Management of Abdominal Myofascial Pain Syndrome (AMPS): A Three-Year Prospective Audit of a Management Pathway in 120 Patients. ( 29444277 )
2018
2
The Distinction of Hot Herbal Compress, Hot Compress, and Topical Diclofenac as Myofascial Pain Syndrome Treatment. ( 29405762 )
2018
3
Concurrent validation of a pressure pain threshold scale for individuals with myofascial pain syndrome and fibromyalgia. ( 29456445 )
2018
4
Challenging the Cinderella Hypothesis: A New Model for the Role of the Motor Unit Recruitment Pattern in the Pathogenesis of Myofascial Pain Syndrome in Postural Muscles. ( 29944114 )
2018
5
The Effectiveness of Dry Needling and Exercise Therapy in Patients with Dizziness Caused By Cervical Myofascial Pain Syndrome; Prospective Randomized Clinical Study. ( 29718418 )
2018
6
Combination of exercise and acupuncture vs acupuncture alone for treatment of myofascial pain syndrome: A randomized clinical trial. ( 29746993 )
2018
7
Prevalence of myofascial pain syndrome in patients with incurable cancer. ( 29861227 )
2018
8
Methodological Issues on the Accuracy and Precision of Clinical Examination in the Diagnosis of Myofascial Pain Syndrome. ( 29788387 )
2018
9
Reply to "Clinical Examination in the Diagnosis of Myofascial Pain Syndrome; Methodological Issues on Validity and Reliability". ( 29788501 )
2018
10
Quantitative Ultrasound Using Texture Analysis of Myofascial Pain Syndrome in the Trapezius. ( 29717675 )
2018
11
Comparision of the effectiveness of ESWT and ultrasound treatments in myofascial pain syndrome: randomized, sham-controlled study. ( 29581669 )
2018
12
A comparison of the clinical manifestation and pathophysiology of myofascial pain syndrome and fibromyalgia: implications for differential diagnosis and management. ( 30270926 )
2018
13
Fibromyalgia and myofascial pain syndrome: Two sides of the same coin? A scoping review to determine the lexicon of the current diagnostic criteria. ( 30350334 )
2018
14
Validity and Reliability of Clinical Examination in the Diagnosis of Myofascial Pain Syndrome and Myofascial Trigger Points in Upper Quarter Muscles. ( 29253210 )
2018
15
Comparison of ozone and lidocaine injection efficacy vs dry needling in myofascial pain syndrome patients. ( 29988746 )
2018
16
High- versus low-energy extracorporeal shock-wave therapy for myofascial pain syndrome of upper trapezius: A prospective randomized single blinded pilot study. ( 29995794 )
2018
17
Comparative study of shockwave therapy and low-level laser therapy effects in patients with myofascial pain syndrome of the trapezius. ( 30171341 )
2018
18
Safety and Efficacy of PrabotulinumtoxinA (Nabota®) Injection for Cervical and Shoulder Girdle Myofascial Pain Syndrome: A Pilot Study. ( 30177597 )
2018
19
Does improvement towards a normal cervical sagittal configuration aid in the management of cervical myofascial pain syndrome: a 1- year randomized controlled trial. ( 30419868 )
2018
20
Insights About the Neuroplasticity State on the Effect of Intramuscular Electrical Stimulation in Pain and Disability Associated With Chronic Myofascial Pain Syndrome (MPS): A Double-Blind, Randomized, Sham-Controlled Trial. ( 30459575 )
2018
21
Does kinesiotaping increase the efficacy of lidocaine injection in myofascial pain syndrome treatment? A randomized controlled study. ( 30507559 )
2018
22
Clinical features and myofascial pain syndrome in older adults with knee osteoarthritis by sex and age distribution: A cross-sectional study. ( 30528723 )
2018
23
Comparision of two different dry-needling techniques in the treatment of myofascial pain syndrome. ( 28467572 )
2017
24
Reliability of assessment of upper trapezius morphology, its mechanical properties and blood flow in female patients with myofascial pain syndrome using ultrasonography. ( 28167187 )
2017
25
Acupuncture for Myofascial Pain Syndrome: A Network Meta-Analysis of 33 Randomized Controlled Trials. ( 28934793 )
2017
26
Far-infrared ray patches relieve pain and improve skin sensitivity in myofascial pain syndrome: A double-blind randomized controlled study. ( 29154057 )
2017
27
Extracorporeal Shock Wave Therapy Versus Trigger Point Injection in the Treatment of Myofascial Pain Syndrome in the Quadratus Lumborum. ( 28971042 )
2017
28
Assess pain intensity using photoplethysmography signal in chronic myofascial pain syndrome. ( 28502104 )
2017
29
Increased Risk of Myofascial Pain Syndrome Among Patients with Insomnia. ( 28339643 )
2017
30
A Multimodal Approach for Myofascial Pain Syndrome: A Prospective Study. ( 28739020 )
2017
31
Effect of dry needling on myofascial pain syndrome of the quadratus femoris: A case report. ( 28922048 )
2017
32
Comparison of the Efficiency of Ultrasound-Guided Injections of the Rhomboid Major and Trapezius Muscles in Myofascial Pain Syndrome: A Prospective Randomized Controlled Double-blind Study. ( 29048132 )
2017
33
Manual acupuncture for myofascial pain syndrome: a systematic review and meta-analysis. ( 28115321 )
2017
34
The effectiveness of Kinesio Taping on pain and disability in cervical myofascial pain syndrome. ( 28343625 )
2017
35
The Possible Role of Meditation in Myofascial Pain Syndrome: A New Hypothesis. ( 28503039 )
2017
36
Effectiveness of ultrasound therapy for myofascial pain syndrome: a systematic review and meta-analysis. ( 28331357 )
2017
37
Quantitative Ultrasound Assessment of Myofascial Pain Syndrome Affecting the Trapezius: A Reliability Study. ( 28670779 )
2017
38
Cutaneous silent period in myofascial pain syndrome. ( 28877555 )
2017
39
Characteristics of Myofascial Pain Syndrome of the Infraspinatus Muscle. ( 28971041 )
2017
40
Correction: Idiopathic Retroperitoneal Fibrosis With Myofascial Pain Syndrome: A Case Report. ( 29201835 )
2017
41
Corticospinal excitability as a biomarker of myofascial pain syndrome. ( 29392210 )
2017
42
Myofascial Pain Syndrome on Tc99m MDP Bone Scintigraphy. ( 28680220 )
2017
43
Comparison between ultrasound-guided interfascial pulsed radiofrequency and ultrasound-guided interfascial block with local anesthetic in myofascial pain syndrome of trapezius muscle. ( 28151904 )
2017
44
Pathophysiology of Trigger Points in Myofascial Pain Syndrome. ( 28379050 )
2017
45
Reliability of the Upper Trapezius Muscle and Fascia Thickness and Strain Ratio Measures by Ultrasonography and Sonoelastography in Participants With Myofascial Pain Syndrome. ( 29276464 )
2017
46
Clinicians' perspective of the current diagnostic criteria for myofascial pain syndrome. ( 27858678 )
2017
47
The effectiveness of kinesio taping on pain and disabilty in cervical myofascial pain syndrome. ( 27036544 )
2016
48
Myofascial Pain Syndrome in the Elderly and Self-Exercise: A Single-Blind, Randomized, Controlled Trial. ( 26910293 )
2016
49
Evaluation of the Sympathetic Skin Response to the Dry Needling Treatment in Female Myofascial Pain Syndrome Patients. ( 27298659 )
2016
50
Prevalence of Myofascial Pain Syndrome in Chronic Non-Specific Neck Pain: A Population-Based Cross-Sectional Descriptive Study. ( 27330152 )
2016

Variations for Myofascial Pain Syndrome

Expression for Myofascial Pain Syndrome

Search GEO for disease gene expression data for Myofascial Pain Syndrome.

Pathways for Myofascial Pain Syndrome

GO Terms for Myofascial Pain Syndrome

Biological processes related to Myofascial Pain Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 neuropeptide signaling pathway GO:0007218 8.96 POMC TAC1
2 regulation of blood pressure GO:0008217 8.62 POMC TAC1

Molecular functions related to Myofascial Pain Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 signaling receptor binding GO:0005102 8.8 PDGFRB POMC TAC1

Sources for Myofascial Pain Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....